FDA Investigator Milos Dokmanovic, PhD

Milos Dokmanovic, PhD has conducted inspections on 4 sites in 3 countries as of 04 Nov 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
4
Last Inspection Date:
04 Nov 2019
Investigator Role:
FDA Investigation Participant
Redica ID:
100001767
Countries of Inspections:
United States of America, Germany, Ireland
FDA Investigators that have inspected at least one site in common with Milos Dokmanovic, PhD:
Amir Alavi, Andrew J Barrowcliff, Anh M Lac, Anita Narula, PhD, Ann L Demarco, Arulvathani P Arudchandran, Ashar P Parikh, Azza Talaat, Bijoy Panicker, Bo Chi, PhD, Brenda W Uratani, PhD, Candace Y Gomez Broughton, Carl A Huffman, III, Carl Lee, Carolyn A Renshaw, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Christopher Downey, PhD, Concepcion Cruz, Jr, David G Eng, Dennis Cantellops Paite, Diane L Raccasi, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Willie Wilson, PhD, Dr. Zhihao Qiu (Peter), PhD, Eliezar Ramos, Erika V Butler, Erin D Mccaffery, Felix Maldonado, Francis A Guidry, Guerlain Ulysse, Henry K Lau, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, James R Evans, Javier E Santos, Jay T Wong, Jeffrey M Watson, Jens Fricke, Jing Fang, John D White, Joseph Kutze, PhD, Julie D Bringger, Junho Pak, Kalavati Suvarna, PhD, Kathleen R Jones, PhD, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kevin A Gonzalez, Kouros Kangarli, Kshitij A Patkar, Kurt A Brorson, PhD, Lakshmi Narasimhan, PhD, Lance Mde Souza, MBA, Laura Fontan, MS, Laurie Graham, LCDR Chad N Thompson, Linan Ha, PhD, Lucila B Nwatu, Margaret E Sarles, Maria Cecilia Tami, PhD, Maria Gutierrez Hoffman, PhD, Maria Joselopez Barragan, PhD, Mariza M Jafary, Mark Brunswick, PhD, Marshalette O Edwards, Mary E Storch, Maxwell Van Tassell, PhD, Michael Shanks, MS, Michelle Rfrazier Jessen, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Mindy M Chou, Monica Commerford, PhD, Mra Davism, Mra Munizn, Natalia Pripuzova, PhD, Nicholas L Hunt, Ogechi C Nna, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul Mouris, Peter E Baker, Prabhu P Raju, Qing Joanna Zhou, PhD, Rajiv R Srivastava, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Richard W Berning, Robert D Tollefsen, Robert J Martin, Robert Jennings, Rose Ashley, Ruth Moore, PhD, Sarah Kennett, PhD, Scott N Lim, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Sony Mathews, Stephanie A Slater, MS, Thomas J Arista, Thuy T Nguyen, LCDR, Tzanko Stantchev, Uttaniti Limchumroon (Tom), Veronica Fuentes, MS, Virgilio F Pacio, CSO, Walter N Lange, Wayne E Seifert, William V Millar, Xu Michael Di, PhD, Yanming An, PhD, Yun Wu, PhD, Zerita White, Zhong Li, PhD, Ziyang Su, PhD

Milos Dokmanovic, PhD's Documents

Publish Date Document Type Title
September, 2018 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2018-09-21
November, 2019 EIR Regeneron Pharmaceuticals, Inc. - EIR, 2020-05-27
March, 2018 FDA 483 Eli Lilly Kinsale Limited - Form 483, 2018-03-16
August, 2016 FDA 483 Genentech, Inc. - Form 483, 2016-08-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more